is ocrevus approved in us
South San Francisco, CA -- March 28, 2017 --. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) approved OCREVUSâ¢ (ocrelizumab) as the first and only medicine for both relapsing and primary progressive forms of multiple sclerosis.